Allocation and funding of Speech and Language Therapy for children with Developmental Language Disorders across Europe and beyond.

Developmental Language Disorder Direct therapy Funding policy Implementation Indirect therapy Mixed therapy Speech and language therapy

Journal

Research in developmental disabilities
ISSN: 1873-3379
Titre abrégé: Res Dev Disabil
Pays: United States
ID NLM: 8709782

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 18 11 2021
accepted: 22 11 2021
pubmed: 4 1 2022
medline: 12 1 2022
entrez: 3 1 2022
Statut: ppublish

Résumé

Children with Developmental Language Disorder (DLD) have a significant deficit in spoken language ability which affects their communication skills, education, mental health, employment and social inclusion. The present study reports findings from a survey by EU network COST ACTION 1406 and aims to explore differences in service delivery and funding of SLT services for children with DLD across Europe and beyond. The survey was completed by 5024 European professionals. COST countries were grouped into Nordic, Anglo-Saxon, Continental, Mediterranean, Central/Eastern and Non-European categories. The use of direct, indirect and mixed interventions, and their relationship to funding available (public, private or mixed) were considered for further analysis. The results revealed that for direct therapy, there were more cases than expected receiving private funding. For indirect therapy, fewer than expected received private and more than expected public funding. For mixed therapy, fewer cases than expected received private funding. The results implies that other factors than evidence-based practices, practitioners experience, and patient preferences, drive choices in therapy. More research is needed to gain a better understanding of factors affecting the choice of therapy.

Sections du résumé

BACKGROUND BACKGROUND
Children with Developmental Language Disorder (DLD) have a significant deficit in spoken language ability which affects their communication skills, education, mental health, employment and social inclusion.
AIM OBJECTIVE
The present study reports findings from a survey by EU network COST ACTION 1406 and aims to explore differences in service delivery and funding of SLT services for children with DLD across Europe and beyond.
METHODS AND PROCEDURES METHODS
The survey was completed by 5024 European professionals. COST countries were grouped into Nordic, Anglo-Saxon, Continental, Mediterranean, Central/Eastern and Non-European categories. The use of direct, indirect and mixed interventions, and their relationship to funding available (public, private or mixed) were considered for further analysis.
OUTCOMES AND RESULTS RESULTS
The results revealed that for direct therapy, there were more cases than expected receiving private funding. For indirect therapy, fewer than expected received private and more than expected public funding. For mixed therapy, fewer cases than expected received private funding.
CONCLUSIONS AND IMPLICATIONS CONCLUSIONS
The results implies that other factors than evidence-based practices, practitioners experience, and patient preferences, drive choices in therapy. More research is needed to gain a better understanding of factors affecting the choice of therapy.

Identifiants

pubmed: 34979356
pii: S0891-4222(21)00288-2
doi: 10.1016/j.ridd.2021.104139
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104139

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Hanne B Søndergaard Knudsen (HBS)

Center for Developmental & Applied Psychological Science (CeDAPS), Aalborg University, Teglgårds Plads 1, 9000, Aalborg, Denmark. Electronic address: hannebsk@hum.aau.dk.

Niloufar Jalali-Moghadam (N)

Blekinge Center of Competence, Blekinge County Council, Sweden; Department of Psychiatry, Østfold Hospital Trust, Moss, Norway.

Silvia Nieva (S)

Complutense University of Madrid, Spain.

Ewa Czaplewska (E)

Institute of Logopaedics, University of Gdansk, Poland.

Marja Laasonen (M)

Logopedics, School of Humanities, Philosophical Faculty, University of Eastern Finland; Department of Psychology and Logopedics, University of Helsinki; Department of Phoniatrics, Helsinki University Hospital, Finland.

Ellen Gerrits (E)

HU University of Applied Sciences Utrecht and Utrecht University, the Netherlands.

Cristina McKean (C)

Newcastle University, UK.

James Law (J)

Newcastle University, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH